STEPHANIE MCQUILLIN: Open Payments
NPI 1023503570 · WASILLA, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,638 in 27 payments from 10 companies in 2025. Trend: 2023 $45 · 2024 $262 · 2025 $3,638
Consulting: $3,109Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 5 | $3,204 |
| Novartis Pharmaceuticals Corporation | 7 | $128 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| AKEBIA THERAPEUTICS INC | 2 | $44 |
| Fresenius USA Marketing, Inc. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Vifor Pharma, Inc. | 1 | $35 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| Ardelyx, Inc. | 1 | $16 |
| Travere Therapeutics, Inc. | 2 | $8 |
Products named: TARPEYO, Fabhalta, JYNARQUE, Vafseo, VELPHORO, Vanrafia, Kerendia, Veltassa.
Industry payments across AK — which companies pay providers there.
